Howard Clowes's most recent trade in Plus Therapeutics Inc was a trade of 297,794 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2025 | 297,794 | 297,794 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 40,122 | 40,122 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 1.34 per share. | 11 Sep 2024 | 5,000 | 26,497 (0%) | 0% | 1.3 | 6,681 | Common Stock |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2024 | 3,650 | 3,650 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 19,608 | 19,608 | - | - | Warrants (Right to buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 08 May 2024 | 9,804 | 21,497 (0%) | 0% | 2.0 | 20,000 | Common Stock |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 3.98 per share. | 06 Jun 2023 | 1,000 | 4,700 (0%) | 0% | 4.0 | 3,980 | Common Stock |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 03 May 2023 | 2,500 | 3,700 (0%) | 0% | 3.6 | 9,102 | Common Stock |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 20,182 | 20,182 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 02 Jun 2022 | 15,000 | 18,000 (0%) | 0% | 0.6 | 8,589 | Common Stock |
| Plus Therapeutics Inc | Howard Clowes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 6,336 | 6,336 | - | - | Stock Option (Right to Buy) | |
| Plus Therapeutics Inc | Howard Clowes | Director | Purchase of securities on an exchange or from another person at price $ 2.42 per share. | 03 Mar 2021 | 3,000 | 3,000 (0%) | 0% | 2.4 | 7,260 | Common Stock |